Insights into the Classification of Cardiomyopathies: Past, Present, and Future Directions

Salemi, Vera Maria Cury; Mohty, Dania; Altavila, Sonia Lages Lustosa de; Melo, Marcelo Dantas Tavares de; Filho, R. Kalil; Bocchi, Edimar Alcides

doi:10.6061/clinics/2021/e2808

Cited by 8 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…За първи път терминът кардиомиопатия е използван през 1957 г. от Wallace Brigden, който описва с него неизвестно некоронарно заболяване на миокарда с неясна етиология [3]. През 1980 г. Световната здравна организация (СЗО) дефинира кардиомиопатията като заболяване на сърдечния мускул с неизвестна етиология, което отразява ограничените познания по отношение на сърдечните заболявания по това време и предлага класификация, която разделя кардиомиопатиите на дилатативни, хипертрофични и рестриктивни.…”

Section: класификация на кардиомиопатиитеunclassified

“…The term cardiomyopathy was first used in 1957 by Wallace Brigden to describe an unknown non-coronary myocardial disease of unclear etiology [3]. In 1980, the World Health Organization (WHO) defined cardiomyopathy as a disease of the heart muscle of unknown etiology, reflecting the limited knowledge of heart diseases at that time, and proposed a classification that divides cardiomyopathies into dilated, hypertrophic, and restrictive.…”

Section: Classification Of Cardiomyopathiesmentioning

confidence: 99%

See 1 more Smart Citation

Role of cardiac magnetic resonance imaging in the diagnosis of nonischemic cardiomyopathies

Partenova¹,

Kostova-Lefterova²,

Genova³

2022

Bulgarian Cardiology

View full text Add to dashboard Cite

In recent decades, cardiac magnetic resonance imaging (CMR) has been established  as a valuable tool in the diagnosis of patients with or at risk of heart failure. With its ability to characterize tissue changes in the myocardium, CMR can provide detailed and clinically useful information about the type and severity of cardiac damage. The method is not only important for differentiation of ischemic from non-ischemic cardiomyopathy, but also contributes to the correct diagnosis of non-ischemic cardiomyopathy subtypes. It is also widely accepted as a reference standard for the quantification of myocardial mass, volumes and ejection fraction. The purpose of this article is to review the role of CMR in the diagnosis and treatment of non-ischemic cardiomyopathies.

show abstract

Section: класификация на кардиомиопатиитеunclassified

Section: Classification Of Cardiomyopathiesmentioning

confidence: 99%

Role of cardiac magnetic resonance imaging in the diagnosis of nonischemic cardiomyopathies

Partenova¹,

Kostova-Lefterova²,

Genova³

2022

Bulgarian Cardiology

View full text Add to dashboard Cite

show abstract

“…The American Heart Association (AHA) in 2006 defined cardiomyopathies as a heterogeneous group of disorders of the myocardium that can change cardiac function (mechanical and/or electrical dysfunction) and structure and lead to heart failure and cardiovascular death [ 1 , 2 , 3 , 4 ]. Cardiomyopathies can be categorized into two main groups according to the prevailing organ involvement and the evolution of genetic testing and diagnostic imaging methods in cardiology [ 5 , 6 ]. Primary cardiomyopathies, which are caused by genetic, nongenetic, and acquired conditions, consist of dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic cardiomyopathy (ACM).…”

Section: Introductionmentioning

confidence: 99%

Circular RNAs: New Players in Cardiomyopathy

Moghaddam

Maleki

Oveisee

et al. 2022

Genes

View full text Add to dashboard Cite

Cardiomyopathies comprise a heterogeneous group of cardiac diseases identified by myocardium disorders and diminished cardiac function. They often lead to heart failure or heart transplantation and constitute one of the principal causes of morbidity and mortality worldwide. Circular RNAs (circRNAs) are a novel type of noncoding RNAs. They are covalently closed and single-stranded and derived from the exons and introns of genes by alternative splicing. This specific structure renders them resistant to exonuclease digestion. Many recent studies have demonstrated that circRNAs are highly abundant and conserved and can play central roles in biological functions such as microRNA (miRNA) sponging, splicing, and transcription regulation. Emerging evidence indicates that circRNAs can play significant roles in cardiovascular diseases, including cardiomyopathies. In this review, we briefly describe the current understanding regarding the classification, nomenclature, characteristics, and function of circRNAs and report recent significant findings concerning the roles of circRNAs in cardiomyopathies. Furthermore, we discuss the clinical application potential of circRNAs as the therapeutic targets and diagnostic biomarkers of cardiomyopathies.

show abstract

Epigenetics of Cardiomyopathy: Histone Modifications and DNA Methylation

Kucher,

Nazarenko

2023

Russ J Genet

View full text Add to dashboard Cite

Insights into the Classification of Cardiomyopathies: Past, Present, and Future Directions

Cited by 8 publications

References 11 publications

Role of cardiac magnetic resonance imaging in the diagnosis of nonischemic cardiomyopathies

Role of cardiac magnetic resonance imaging in the diagnosis of nonischemic cardiomyopathies

Circular RNAs: New Players in Cardiomyopathy

Epigenetics of Cardiomyopathy: Histone Modifications and DNA Methylation

Contact Info

Product

Resources

About